Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
14 nov. 2017 07h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today...
Neuronascent Appoints New Board Member
12 avr. 2017 06h30 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - April 12, 2017) - Neuronascent, Inc., a neuro-pharmaceutical company developing proprietary therapeutics for Alzheimer's disease, Parkinson's disease, and psychiatric...
Neuronascent Announces Third US Patent Issued Covering Therapeutics for Neurodegenerative and Neuropsychiatric Disorders
24 janv. 2017 06h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - January 24, 2017) - Neuronascent's U.S. Patent No. 9,539,261, which issued on January 10, 2017, claims methods of stimulating neurogenesis and/or inhibiting neuronal...
Neuronascent Secures Financing for Development of Its Alzheimer's Therapeutic
06 avr. 2015 06h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Apr 6, 2015) - Neuronascent, a biopharmaceutical company developing non-invasive, neuron regenerative therapeutics aimed at reversing cognitive deficits in...
Neuronascent Announces Expanded Patent Coverage in US and Russia for Its Alzheimer's Disease and Down Syndrome Therapeutics
05 févr. 2015 06h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Feb 5, 2015) - The US Patent Office issued an allowance to Neuronascent, Inc. expanding patent protection of their new therapeutic candidate, NNI-362, beyond...
Neuronascent Successfully Completes Pre-IND Meeting With FDA for Alzheimer's Disease Therapeutic
22 avr. 2014 06h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Apr 22, 2014) - Neuronascent, Inc. (www.neuronascent.com), a company focused on developing its novel therapeutic candidates for new neuron formation in Alzheimer's...
Neuronascent, Inc. Announces Issuance of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate
29 janv. 2014 07h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jan 29, 2014) - Neuronascent, Inc. announced today the issuance of the United States patent covering a new compound family that includes Neuronascent's lead...
Neuronascent, Inc. Alzheimer's Disease Therapeutic Candidate Selected for Preclinical Safety Testing
19 nov. 2013 07h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Nov 19, 2013) - Neuronascent, Inc. (www.neuronascent.com) announced today that preclinical development of Neuronascent's (the "Company") innovative Alzheimer's...
Neuronascent, Inc. Announces Issuance of Canadian Patent Covering Its Lead Alzheimer's Disease Candidate
25 juin 2013 12h39 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jun 25, 2013) - Neuronascent, Inc. announced today the issuance of a Canadian patent covering its compound families that include Neuronascent's Alzheimer's...
Neuronascent Issued US Patent for Neurogenesis, Therapeutic Candidates
26 oct. 2011 12h51 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwire - Oct 26, 2011) - Neuronascent, Inc. (www.neuronascent.com) announced today that the USPTO has allowed claims for its patent, "Methods and Compositions for Stimulating...